指南与共识胸部CT

南非内镜下肺减容术2022立场声明更新

Position statement on endoscopic lung volume reduction in South Africa: 2022 update.
指南 / 共识 · Afr J Thorac Crit Care Med · 2022-06-20

南非胸科学会更新2022年立场声明,基于A级证据推荐对特定晚期肺气肿患者使用内镜下肺减容术。患者需满足年龄40-75岁、重度呼吸困难、FEV1 20-50%、过度充气及6分钟步行距离100-450米等条件,且无严重肺动脉高压等禁忌证。评估重点包括HRCT上肺实质破坏程度和叶间侧支通气。

要点

  • ELVR适用于40-75岁、FEV1 20-50%、RV>175%或RV/TLC>55%的晚期肺气肿患者。
  • HRCT评估肺实质破坏范围和叶间侧支通气是筛选靶肺叶的关键。
  • 严重肺动脉高压等禁忌证需排除,6MWD 100-450米(康复后)为参考条件。

局限性

  • 原文未报告系统检索策略和证据分级方法。
  • 声明主要基于专家意见和现有指南,缺乏原始研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Chronic obstructive pulmonary disease (COPD) remains one of the most common causes of morbidity and mortality in South Africa. Endoscopic lung volume reduction (ELVR) was first proposed by the South African Thoracic Society (SATS) for the treatment of advanced emphysema in 2015. Since the original statement was published, there has been a growing body of evidence that a certain well-defined sub-group of patients with advanced emphysema may benefit from ELVR, to the point where the current Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines and the United Kingdom National Institute for Health and Care Excellence (NICE) advocate the use of endoscopic valves based on level A evidence. Patients aged 40 - 75 years with severe dyspnoea (COPD Assessment Test score ≥10) despite maximal medical therapy and pulmonary rehabilitation, with forced expiratory volume in one second (FEV1) 20 - 50%, hyperinflation with residual volume (RV) >175% or RV/total lung capacity (TLC) >55% and a six-minute walking distance (6MWD) of 100 - 450 m (post-rehabilitation) should be referred for evaluation for ELVR, provided no contraindications (e.g. severe pulmonary hypertension) are present. Further evaluation should focus on the extent of parenchymal tissue destruction on high-resolution computed tomography (HRCT) of the lungs and interlobar collateral ventilation (CV) to identify a potential target lobe. Commercially available radiology software packages and/or an endobronchial catheter system can aid in this assessment. The aim of this statement is to provide the South African medical practitioner and healthcare funders with an overview of the practical aspects and current evidence for the judicious use of the valves and other ELVR modalities which may become available in the country.

来源:Afr J Thorac Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Koegelenberg, van Zyl-Smit, Dheda, et al. Position statement on endoscopic lung volume reduction in South Africa: 2022 update. Afr J Thorac Crit Care Med. 2022. PMID: 35919923. doi:10.7196/AJTCCM.2022.v28i2.249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。